Jul 6, 2024, 10:23
Pierre Blanchard: Silke Gillessen and Bertrand Tombal, on intermittent ADT/ARPI in metastatic prostrate cancer
Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X:
“Excellent discussion by Silke Gillessen, Bertrand Tombal, on intermittent ADT/ARPI in hormone naïve metastatic prostrate cancer at GETUG research days.
New trials needed, especially for patients with deep PSA response (<0,2 ng/ml) after dual ADT/ARPI.”
Source: Pierre Blanchard/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 1, 2024, 19:12
Nov 1, 2024, 17:46
Nov 1, 2024, 17:41
Nov 1, 2024, 17:27